2.3 Million Units of Cold and Cough Syrup Recalled
The manufacturers of Triaminic and Theraflu has recalled 2.3 million units of these products as the child resistant caps on them were not effective and four children were able to open them and ingest the contents.
The United States Consumer Product Safety Commission has stated that the child-resistant caps in some bottles of Triaminic and Theraflu are not effective and can be opened by children though the tamper-evident plastic seal was existent. This federal agency is responsible for the protection of consumers against possibly hazardous products.
Following the statement, Novartis Consumer Health Inc., the pharmaceutical company which manufacture these medicines recalled six varieties of Theraflu Warming Relief Syrups and 18 varieties of Triaminic syrups. Meanwhile one of the four children who ingested the medicine needed medical care, while eight other children were able to open the cap, however, did not ingest the content.
Novartis recalled these medicines voluntarily following an internal investigation responding to a customer complaint. These syrups are particularly appealing to the children's taste as they come in different flavors like cherry, grapes to make them easily consumable. So the children either observe where their parents keep these bottles or the parents keep the bottles on the counter.
Following the approval of the U.S. Poison Prevention Packaging Act in 1970, childproof or child-resistant caps have become mandatory.